Pharmacokinetic and pharmacodynamic analysis of bis-acetato-ammine-dichloro-cyclohexylamine-platinum(IV) (JM216) administered once a day for five consecutive days: a phase I study.
about
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) ProdrugsSatraplatin: leading the new generation of oral platinum agentsPhase 1 trial and pharmacokinetic study of the oral platinum analog satraplatin in children and young adults with refractory solid tumors including brain tumors.Chemotherapy in Androgen-Independent Prostate Cancer (AIPC): What's next after taxane progression?An open-label, dose-finding study of the combination of satraplatin and gemcitabine in patients with advanced solid tumors.Satraplatin: an orally available platinum analog for the treatment of cancer.Satraplatin for the therapy of castration-resistant prostate cancer.Platinum-based compounds for the treatment of metastatic breast cancer.Satraplatin in the treatment of hormone-refractory prostate cancer.The plasma and cerebrospinal fluid pharmacokinetics of the platinum analog satraplatin after intravenous administration in non-human primates.A comparative study of pharmacokinetics, urinary excretion and tissue distribution of platinum in rats following a single-dose oral administration of two platinum(IV) complexes LA-12 (OC-6-43)-bis(acetato)(1-adamantylamine)amminedichloroplatinum(IV)
P2860
Q28066801-C797F9EC-2B42-472B-B16E-2737AFB1CD65Q28972468-B923271F-C0E2-47BE-9706-F577DC7BF96FQ35118358-972B60FC-9A63-4EB8-BA1A-EE1878BD2C3EQ35945262-979C2D1C-D1FE-4995-A1E5-66028FAD0E57Q36417757-54195F41-B355-4AA2-9ECF-BFA1D2E8DA38Q36532071-C127B15C-8BD4-4ED3-BF72-C52A07406BD7Q37605845-9F443EEC-AB93-403F-9F20-FD283596BC7FQ37976172-2678044F-DD25-4FE4-B4CB-DF9F6AC6FCB1Q46753215-5DF0C8F9-3C5B-4B01-99FF-F278C12F0EC8Q49123833-19655475-BB9B-42AC-9A95-3F084D18CCB9Q51672482-683DF884-7808-48AE-958D-014699653740
P2860
Pharmacokinetic and pharmacodynamic analysis of bis-acetato-ammine-dichloro-cyclohexylamine-platinum(IV) (JM216) administered once a day for five consecutive days: a phase I study.
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Pharmacokinetic and pharmacody ...... hloro-cyclohexylamine-platinum
@nl
Pharmacokinetic and pharmacody ...... ecutive days: a phase I study.
@ast
Pharmacokinetic and pharmacody ...... ecutive days: a phase I study.
@en
type
label
Pharmacokinetic and pharmacody ...... hloro-cyclohexylamine-platinum
@nl
Pharmacokinetic and pharmacody ...... ecutive days: a phase I study.
@ast
Pharmacokinetic and pharmacody ...... ecutive days: a phase I study.
@en
prefLabel
Pharmacokinetic and pharmacody ...... hloro-cyclohexylamine-platinum
@nl
Pharmacokinetic and pharmacody ...... ecutive days: a phase I study.
@ast
Pharmacokinetic and pharmacody ...... ecutive days: a phase I study.
@en
P2093
P356
P1476
Pharmacokinetic and pharmacody ...... ecutive days: a phase I study.
@en
P2093
P304
P356
10.1093/JJCO/HYD102
P577
2000-09-01T00:00:00Z